000			02138 a2200601 4500
005			20250517020842.0
264		0	_c20160323
008			201603s 0 0 eng d
022			_a1573-2509
024	7		_a10.1016/j.schres.2015.01.041 _2doi
040			_aNLM _beng _cNLM
100	1		_aJarskog, L Fredrik
245	0	0	_aA Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. _h[electronic resource]
260			_bSchizophrenia research _cMay 2015
300			_a136-42 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntipsychotic Agents _xtherapeutic use
650	0	4	_aBenzazepines _xtherapeutic use
650	0	4	_aCognition Disorders _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHistamine Antagonists _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeuropsychological Tests
650	0	4	_aPsychiatric Status Rating Scales
650	0	4	_aSchizophrenia _xcomplications
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aLowy, Martin T
700	1		_aGrove, Richard A
700	1		_aKeefe, Richard S E
700	1		_aHorrigan, Joseph P
700	1		_aBall, M Patricia
700	1		_aBreier, Alan
700	1		_aBuchanan, Robert W
700	1		_aCarter, Cameron S
700	1		_aCsernansky, John G
700	1		_aGoff, Donald C
700	1		_aGreen, Michael F
700	1		_aKantrowitz, Joshua T
700	1		_aKeshavan, Matcheri S
700	1		_aLaurelle, Marc
700	1		_aLieberman, Jeffrey A
700	1		_aMarder, Stephen R
700	1		_aMaruff, Paul
700	1		_aMcMahon, Robert P
700	1		_aSeidman, Larry J
700	1		_aPeykamian, Margaret A
773	0		_tSchizophrenia research _gvol. 164 _gno. 1-3 _gp. 136-42
856	4	0	_uhttps://doi.org/10.1016/j.schres.2015.01.041 _zAvailable from publisher's website
999			_c24667048 _d24667048